Houston (1)

Completed (1)

phase 1/phase 2 (1)

M.D. Anderson Cancer Center (1)

National Cancer Institute (NCI) (1)

aldesleukin (1)

allogeneic cd56-positive cd3-negative natural killer cells (1)

allogeneic hematopoietic stem cell transplantation (1)

busulfan (1)

fludarabine phosphate (1)

laboratory biomarker analysis (1)

peripheral blood stem cell transplantation (1)

pharmacological study (1)

biological (1)

drug (1)

other (1)

procedure (1)

Other (1)

Interventional (1)

blasts under 20 percent of peripheral blood white cells

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Completed

Jul 31, 2022